Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Carcinoma in situ
ADR ID BADD_A05904
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.006      Carcinoma in situ
Description A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. [MeSH]
MedDRA Code 10061450
MeSH ID D002278
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer in situ NOS | Carcinoma in situ NOS | Carcinoma in situ of breast and genitourinary system | Carcinoma in situ of other and unspecified sites | Carcinoma in situ of other specified sites | Carcinoma in situ, site unspecified | In situ cancer | Carcinoma in situ | Carcinoma in Situ | Carcinoma, Preinvasive | Preinvasive Carcinoma | Carcinoma, Intraepithelial | Intraepithelial Carcinoma | Neoplasms, Intraepithelial | Intraepithelial Neoplasm | Neoplasm, Intraepithelial | Intraepithelial Neoplasms
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00680Dimethyl fumarate0.000400%
BADD_D01281Levonorgestrel0.000946%
BADD_D01802Porfimer--
BADD_D02464Fingolimod0.000723%
The 1th Page    1    Total 1 Pages